Atherosclerosis in Rheumatoid Arthritis by Miguel A. González-Gay, Zoltan Szekanecz, Calin D. Popa, Patrick Dessein

Get full text

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals by Calin D. Popa, Elke Arts, Jaap Fransen, Piet L. C. M. van Riel

Get full text

Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis. by Jaap Fransen, Seyyed M R Kazemi-Bajestani, Sebastian J H Bredie, Calin D Popa

Get full text

Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial by Merel Hartog, Kyra A. L. van Keeken, Cornelia H. M. van den Ende, Calin D. Popa

Get full text

Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study by Daphne C. Rohrich, Eline H. M. van de Wetering, Alexander J. Rennings, Elke E. Arts, Inger L. Meek, Alfons A. den Broeder, Jaap Fransen, Calin D. Popa

Get full text

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial by Maarten Boers, Michael T Nurmohamed, Calin D Popa, Dirkjan van Schaardenburg, Marian van Beers-Tas, Laurette van Boheemen, Samina Turk, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Alper van Sijl

Get full text